Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926523 · ClinicalTrials.gov registry record
Biomarkers in the Evaluation of Chronic Lung Disease
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 67
- Enrollment target
NCT00926523 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 67 participants.
The verdict
NCT00926523 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
We hypothesize that hypoxia-induced pulmonary vascular remodeling is mediated by macrophage migration inhibitory factor (MIF), that remodeling is in fact the reflection of a chronic inflammatory process, and that MIF may be a useful biomarker of the severity and progression of both ILD and PH.
Interventions
- OTHER Spirometry
- OTHER Blood Gas
- OTHER Pulmonary Exercise Test
- OTHER Breath Condensate Collector
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926523
The ClinicalTrials.gov registry entry for NCT00926523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Spirometry is the first listed.
NCT00926523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00926523 about?
NCT00926523 is a clinical study titled "Biomarkers in the Evaluation of Chronic Lung Disease". We hypothesize that hypoxia-induced pulmonary vascular remodeling is mediated by macrophage migration inhibitory factor (MIF), that remodeling is in fact the reflection of a chronic inflammatory process, and that MIF may be a useful biomarker of the severity and progression of both ILD and PH.
What is the current status of trial NCT00926523?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2009-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00926523?
The interventions under investigation include: Spirometry (OTHER), Blood Gas (OTHER), Pulmonary Exercise Test (OTHER), Breath Condensate Collector (OTHER).
Who is sponsoring clinical trial NCT00926523?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.